Reference
Yamaoka K, et al. The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. Drug Safety : 27 May 2021. Available from: URL: http://doi.org/10.1007/s40264-021-01067-x
Rights and permissions
About this article
Cite this article
Upadacitinib increases herpes zoster rate in Japanese patients. Reactions Weekly 1859, 12 (2021). https://doi.org/10.1007/s40278-021-97108-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97108-2